CYP2C19 (CYTOCHROME P450 FAMILY 2 SUBFAMILY C MEMBER
DOI:
https://doi.org/10.5281/zenodo.18580616Abstract
Helicobacter pylori infection is widely prevalent worldwide and increases the risk of peptic ulcer disease, gastritis, and gastric cancer. Antibiotic resistance and individual pharmacokinetic variability lead to failure of eradication therapy [1]. The efficacy of proton pump inhibitors (PPIs) depends on their metabolism by the CYP2C19 enzyme, and genetic polymorphisms significantly influence individual treatment outcomes [2]. This study protocol aims to optimize the H. pylori eradication regimen by implementing personalized PPI dosing based on CYP2C19 genotyping. The study is designed as a prospective, randomized clinical trial, and the outcomes are intended to evaluate eradication success according to CYP2C19 genotypes.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting a paper to the conference organized by Academic Publishing House, the author(s) agree to the following license terms and conditions:
1. Copyright and Licensing
- The author(s) retain the copyright of their article.
- The author(s) grant Academic Publishing House a non-exclusive license to publish, distribute, and archive the submitted material in both electronic and print formats.
- The work will be published under the Creative Commons Attribution (CC BY 4.0) license, allowing others to share and adapt the material for any purpose, provided proper credit is given to the original author(s).
2. Author’s Responsibilities
- The author(s) guarantee that the submitted work is original, does not infringe any existing copyrights, and has not been published or submitted elsewhere.
- The author(s) confirm that all co-authors have approved the final version of the manuscript and agree with its submission and publication.
- The author(s) are fully responsible for the accuracy of the data, citations, and references provided in the article.
3. Publisher’s Rights
- Academic Publishing House reserves the right to edit, format, and make minor grammatical or layout corrections to the paper without altering its core content.
- The publisher has the right to include the article in indexing databases, archives, and repositories such as Google Scholar, Zenodo, OpenAIRE, and other partner platforms.
- The publisher may promote the paper through its website and official social media channels.
4. Open Access Policy
All conference papers are published as open access, ensuring free and permanent online access to the full text of all articles immediately upon publication.
5. Withdrawal and Retraction
If ethical misconduct, plagiarism, or data manipulation is detected, Academic Publishing House reserves the right to withdraw or retract the publication at any stage.
6. Acceptance of Terms
Submission of a manuscript to the conference implies that the author(s) have read, understood, and accepted these License Terms.
